Celularity Inc
For the period ended Jun 30, 2024. Filed Nov 7, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Nov 7, 2024
CELU$0.71-6.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets
(In thousands, except share and per share amounts)
| June 30,2024 | December 31,2023 | |
|---|---|---|
| (unaudited) | ||
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $467 | $227 |
| Accounts receivable, net of allowance of $6,143 and $5,837 as of June 30, 2024 and December 31, 2023, respectively | 13,472 | 10,046 |
| Notes receivable | - | 2,072 |
| Inventory | 2,915 | 5,753 |
| Prepaid expenses and other current assets | 877 | 1,695 |
| Total current assets | 17,731 | 19,793 |
| Property and equipment, net | 64,727 | 67,828 |
| Goodwill | 7,347 | 7,347 |
| Intangible assets, net | 9,999 | 11,001 |
| Right-of-use assets - operating leases | 10,903 | 10,990 |
| Restricted cash | 10,087 | 9,936 |
| Inventory, net of current portion | 14,395 | 16,657 |
| Other long-term assets | 305 | 337 |
| Total assets | $135,494 | $143,889 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | $13,726 | $14,144 |
| Accrued expenses and other current liabilities | 10,384 | 7,580 |
| Accrued R&D software | - | 3,500 |
| Short-term debt - unaffiliated (includes debt measured at fair value of $2,985 at June 30, 2024 and $17,223 at December 31, 2023, respectively) | 5,243 | 19,331 |
| Short-term debt - related parties | 35,756 | 19,909 |
| Deferred revenue | 2,791 | 2,834 |
| Total current liabilities | 67,900 | 67,298 |
| Deferred revenue, net of current portion | 3,439 | 3,186 |
| Acquisition-related contingent consideration | 1,606 | 1,606 |
| Noncurrent lease liabilities - operating | 26,356 | 26,177 |
| Warrant liabilities | 8,086 | 4,359 |
| Deferred income tax liabilities | 9 | 9 |
| Other liabilities | 287 | 294 |
| Total liabilities | 107,683 | 102,929 |
| Commitments and contingencies (Note 9) | ||
| Stockholders’ equity | ||
| Preferred stock, $0.0001 par value, 10,000,000 shares authorized, none issued and outstanding at June 30, 2024 and December 31, 2023 | - | - |
| Common Stock, $0.0001 par value, 730,000,000 shares authorized, 21,933,861 issued and outstanding as of June 30, 2024, 19,378,192 issued and outstanding as of December 31, 2023 | 2 | 2 |
| Additional paid-in capital | 898,101 | 882,749 |
| Accumulated deficit | (870,292) | (841,791) |
| Total stockholders’ equity | 27,811 | 40,960 |
| Total liabilities and stockholders’ equity | $135,494 | $143,889 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.